The MOF did indeed break out north as was suggested by the technicals.
Having hit resistance from several weeks ago, price has stalled and appears to be now waiting for the 200 EMA to catch up.
I expect price to drift sideways for several days now and when the 200 EMA is met then we could see price use the 200 as a springboard to break the resistance and move...
Molecular Future has (apparently) arrested its steady decline for the last 8 weeks and is tracking sideways.
Price is now trapped between a rising trend line and the 200 EMA in a clear flag or pennant formation.
Which way it breaks is anyones guess but it looks as if we shall see price break out either up or down over the next few days.
I remain mildly BULLISH on...
Molecular Data has plenty of insider holdings, as well as institutional, signifying continued faith in the companies future prospects. The institutional shares at ~16% could pose a selling hazard eventually, as MKD doesn't have history of growth, if the company fails to deliver upon expectations. At the same time, such a large number shows obvious interest for a...
Blood diagnostic OncoCEE-BR was used by Columbia University College of Physicians and Surgeons in New York City to aid cancer patients' diagnosis. Involved biopsies are no longer required, cancer can be detected with a simple blood test. The chart has strong bullish divergence, has just made a breakout with an initial target around 4 dollars.
